TrialBritish journal of clinical pharmacology2013
Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man.
Ethan Hoffmann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
77 papers cite itlatest 60 shown
this papertrialcites it